Your browser doesn't support javascript.
loading
Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19.
Hong, Jin Yeong; Ko, Jae-Hoon; Yang, Jinyoung; Ha, Soyoung; Nham, Eliel; Huh, Kyungmin; Cho, Sun Young; Kang, Cheol-In; Chung, Doo Ryeon; Baek, Jin Yang; Sohn, You Min; Park, Hyo Jung; Lee, Beomki; Huh, Hee Jae; Kang, Eun-Suk; Suh, Gee Young; Chung, Chi Ryang; Peck, Kyong Ran.
Afiliación
  • Hong JY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ko JH; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Yang J; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ha S; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Nham E; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Huh K; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Cho SY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang CI; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Chung DR; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Baek JY; Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Korea.
  • Sohn YM; Department of Pharmaceutical Services, Samsung Medical Center, Sungkyunkwan University School of Pharmacy, Suwon, Korea.
  • Park HJ; Department of Pharmaceutical Services, Samsung Medical Center, Sungkyunkwan University School of Pharmacy, Suwon, Korea.
  • Lee B; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Huh HJ; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang ES; Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Suh GY; Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Chung CR; Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. chiryang.chung@gmail.com.
  • Peck KR; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. krpeck@skku.edu.
Yonsei Med J ; 63(5): 430-439, 2022 May.
Article en En | MEDLINE | ID: mdl-35512745
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Yonsei Med J Año: 2022 Tipo del documento: Article Pais de publicación:
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Yonsei Med J Año: 2022 Tipo del documento: Article Pais de publicación: